Eyetech Pharmaceuticals, Inc.
666 Fifth Avenue, 35th Floor
New York
New York
10103
United States
Tel: 212-582-8376
Fax: 212 582-2645
Website: http://www.eyetk.com/
27 articles about Eyetech Pharmaceuticals, Inc.
-
Proceeds will be used to assemble and develop a diversified pipeline of therapies to address sight-threatening illnesses.
-
Thomas W. Burns, CEO of Glaukos, Joins Avedro’s Board of Directors
7/31/2018
Avedro, Inc. today announced that Thomas W. Burns has been elected to its Board of Directors.
-
OSI Pharmaceuticals, Inc. to Divest Eye-Disease Program
7/27/2007
-
The Day In Review: OSI Pharmaceuticals, Inc. Gives Up On Macugen
11/7/2006
-
Lux Biosciences Appoints To Board Of Directors David Guyer, SVLS Venture Partner And Former CEO Of Eyetech Pharmaceuticals, Inc.
7/11/2006
-
OSI Pharmaceuticals, Inc. To Host Conference Call To Discuss (OSI) Eyetech Pharmaceuticals, Inc. Integration Strategy
11/16/2005
-
OSI Pharmaceuticals, Inc. Completes Its Acquisition Of Eyetech Pharmaceuticals, Inc.
11/14/2005
-
OSI Pharmaceuticals, Inc. Updates Status Of Pending Acquisition Of Eyetech Pharmaceuticals, Inc.
11/10/2005
-
Eyetech Pharmaceuticals, Inc. Merger Delayed Over Drug Concerns
11/10/2005
-
Eyetech Pharmaceuticals, Inc. Reports Third Quarter 2005 Financial Results
11/1/2005
-
The Week In Review: Highest Weekly Close For Biotech In 2005
7/11/2005
-
The Day In Review: Biotech Takes First Loss In A Week
5/5/2005
-
The Week In Review: From Optimism To Pessimism In Three Short Weeks
3/27/2005
-
Biotech Class Of 2004
1/19/2005
-
JP Morgan Healthcare Conference: Monday’s Observations
1/7/2005
-
Biotech 2005: New Drugs Hold The Key
12/29/2004
-
The Day In Review: Biotech Flat As Market Moves Up A Little
12/23/2004
-
The Week In Review: Biotech Beats The News Blues
12/20/2004
-
JDS Pharmaceuticals Raises $62 Million; Acquires Two Products
11/17/2004
-
Semi-Annual Changes To The NASDAQ Biotechnology Index
11/15/2004